Effects of gender and head size on the auditory brainstem response
The aims of this study were to summarize the clinical manifestations and audiological characteristics of AN, to explore the roles of pure tone audiometry, acoustic immittance test, auditory brainstem response
test and distortion product (DP) otoacoustic emission test in AN diagnosis, to investigate whether AN was complicated with vestibular function disorders or other nervous system diseases, and importantly, to provide valuable evidence for future clinical and experimental studies on AN.
Comparison of auditory steady-state responses and auditory brainstem responses
in audiometric assessment of adults with sensorineural hearing loss.
Preoperative characteristics of auditory brainstem response
in acoustic neuroma with useful hearing: importance as a preliminary investigation for intraoperative monitoring.
Automated auditory brainstem response
testing for universal newborn hearing screening.
Electrophysiologic assessment of central auditory processing by auditory brainstem responses
in participants with autism spectrum disorders.
Normative auditory brainstem response
data for bone conduction in the dog.
A comparison of the effects of isoflurane and ketamine anesthesia on auditory brainstem response
(ABR) thresholds in rats.
Tympanogram showed type B with failed auditory brainstem response
on the affected side and normal hearing on the right side.
In this study, SDS in the audiometric test did not show retrocochlear involvement, but auditory brainstem response
(ABR) assessment would have helped to distinguish not only the central pathways but also the brainstem neural integrity.
The Auditory Brainstem Response
(ABR) is a commonly used test that evaluates the integrity of the auditory nerve and brainstem structures, whereas measures from the auditory evoked late response reflect cortical processing .
Chapters cover aural immittance measures, otoacoustic emission, electrocochleography, auditory brainstem response
, and auditory steady-state response, and give recommendations for objective identification and diagnosis of hearing loss.
All infants should be screened by a physiologic measure such as noninvasive otoacoustic emission (OAE) or auditory brainstem response
(ABR) during the first month of life.
In addition to the impairments that can be detected through central auditory processing tests, electrophysiological abnormalities can also be identified through the measurement of the auditory brainstem response
and the P300 components of the late auditory evoked potential [16-18].
The first, known as the auditory brainstem response
, or ABR, measures the brain's response to sound using earphones and small electrodes, which are taped to the baby's head.